Asarfi Hospital Limited submitted an intimation to BSE Limited regarding the submission of a press release containing extracts of unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company reported record quarterly performance with significant margin expansion. Q2 FY27 standalone revenue increased 18% year-over-year to ₹5,286.83 lakhs (₹52.87 crore), representing the highest-ever quarterly revenue. EBITDA grew 34% and profit after tax (PAT) increased 43% year-over-year. EBITDA margin expanded to 22.5% compared to 19.9% in the same quarter previous year, while PAT margin improved to 11.6% from 9.6%.
Operational Performance
Operational momentum was strong across both inpatient (IPD) and outpatient (OPD) departments. IPD revenue grew 17% year-over-year while OPD revenue surged 39% year-over-year, driven by higher patient volumes. The Super-Specialty unit achieved an Average Revenue Per Occupied Bed (ARPOB) of ₹23,716, representing a 17% increase. The number of surgeries performed grew 25% to 2,295 procedures.
Growth Drivers
The company attributed its growth to several factors: an expanded network of 1,500 referring doctors, widened geographical reach from 7 to 10 districts, new insurance tie-ups, and establishment of outreach clinics. Strong growth was observed specifically in Paediatrics, Neurosciences, Obstetrics & Gynaecology, and Orthopaedics departments.
Financial Results Summary (Standalone)
- Revenue from operations: ₹5,286.83 lakhs (Q2 FY26: ₹4,484.67 lakhs)
- Other Income: ₹70.89 lakhs (Q2 FY26: ₹79.75 lakhs)
- Total Income: ₹5,357.72 lakhs (Q2 FY26: ₹4,564.41 lakhs)
- Profit before Taxes: ₹828.71 lakhs (Q2 FY26: ₹575.85 lakhs)
- Profit after Taxes: ₹614.01 lakhs (Q2 FY26: ₹430.41 lakhs)
- Paid-up Equity Share Capital: ₹1,967.73 lakhs (unchanged)
- Basic EPS: ₹3.12 (Q2 FY26: ₹2.19)
- Diluted EPS: ₹3.12 (Q2 FY26: ₹2.19)
Financial Results Summary (Consolidated)
- Revenue from operations: ₹5,303.81 lakhs (Q2 FY26: ₹4,489.06 lakhs)
- Other Income: ₹68.20 lakhs (Q2 FY26: ₹75.92 lakhs)
- Total Income: ₹5,372.01 lakhs (Q2 FY26: ₹4,564.98 lakhs)
- Profit before Taxes: ₹823.95 lakhs (Q2 FY26: ₹565.17 lakhs)
- Profit after Taxes: ₹609.26 lakhs (Q2 FY26: ₹419.74 lakhs)
- Paid-up Equity Share Capital: ₹1,967.73 lakhs (unchanged)
- Basic EPS: ₹3.10 (Q2 FY26: ₹2.13)
- Diluted EPS: ₹3.10 (Q2 FY26: ₹2.13)
Governance and Compliance
The unaudited standalone and consolidated financial results for the quarter ended September 30, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on November 13, 2026. The results were filed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The full format of the financial results is available on the websites of Bombay Stock Exchange and the company's website at www.asarfi.in.
Company Background
Asarfi Hospital Limited is a Dhanbad-based healthcare provider with a 20-year operating track record, operating two hospitals across super-specialty and oncology care. The company delivers integrated healthcare services including critical care, emergency care, cardiac care, oncology, diagnostics, and other multi-specialty services.